| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 24 Sep 2024 | 19 Aug 2024 |
| AGM 24/09/2024 Kindly find enclosed the proceedings of 32nd AGM of the Company held on September 24, 2024 (As Per BSE Announcement dated on 24.09.2024) Kindly find enclosed the Voting results and scrutinizer report of e-voting held at the 32nd AGM (As per BSE Announcement Dated on 25/09/2024) | ||
The US Food and Drug Administration (FDA) approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
